The Toronto Stock Exchange reports that Medexus Pharmaceuticals Inc. will list an additional 7.5 million shares at the open on Jan. 31, 2025. According to the TSX, the listing will cover shares to be issued at $4, pursuant to the terms of the prospectus supplement dated Jan. 28, 2025, to the short form base shelf prospectus dated Nov. 15, 2024.
© 2025 Canjex Publishing Ltd. All rights reserved.